The carriers of TP53 pathogenic variants were found in 6% of such patients in aforementioned French study and similar frequencies (3.8–7.7%) were reported by Fortuno et al. who reviewed 59 breast cancer studies analyzing the germline TP53 variants in female patients diagnosed at age < 30 years29,31. The gene discussed is TP53; the disease is breast carcinoma.